TRIMTECH Therapeutics
Entry
2025
Hold
1yr
Status
Active
Who owns TRIMTECH Therapeutics?
TRIMTECH Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2025. Across its history, TRIMTECH Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-05-29
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
SV Health ManagersActive
2023 · present(3yr) · Dementia Discovery Fund · 2015 · Impact
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track TRIMTECH Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on TRIMTECH Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue